Entrada Therapeutics, Inc.
Pharmaceutical company · Boston, Massachusetts, United States · Nasdaq: TRDA
Entrada Therapeutics, Inc. is a pharmaceutical company headquartered in Boston, Massachusetts, United States. Its earliest recorded incorporation is in 2016. Its shares trade on Nasdaq under the ticker TRDA. It has reported private securities offerings to the US SEC, most recently $116 million sold in a notice filed in 2021.
Entrada Therapeutics at a glance
What does Entrada Therapeutics do?
Private fundraising reported to the SEC
4 Form D notices; the most recent reported $116.2 million sold (2021).
Frequently asked questions about Entrada Therapeutics
Where is Entrada Therapeutics headquartered?
Entrada Therapeutics, Inc. is headquartered in Boston, Massachusetts, United States.
What does Entrada Therapeutics do?
Entrada Therapeutics, Inc. is a pharmaceutical company. Its SEC industry classification is Pharmaceutical Preparations.
Is Entrada Therapeutics a public company?
Yes. Entrada Therapeutics, Inc. trades on Nasdaq under the ticker TRDA.
When was Entrada Therapeutics founded?
The earliest incorporation on record for Entrada Therapeutics, Inc. is in 2016, according to public company registers.
Similar companies
- Transcode Therapeutics, Inc.Boston, Massachusetts, United States
- Akouos, Inc.Boston, Massachusetts, United States
- Astria Therapeutics, Inc.Boston, Massachusetts, United States
- Albireo Pharma, Inc.Boston, Massachusetts, United States
- Atea Pharmaceuticals, Inc.Boston, Massachusetts, United States
- Rhythm Pharmaceuticals, Inc.Boston, Massachusetts, United States
- Tango Therapeutics, Inc.Boston, Massachusetts, United States
- Paratek Pharmaceuticals, Inc.Boston, Massachusetts, United States
Need a CRO or CDMO for your next study?
Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.
Compare quotesSources
Location data: GeoNames (geonames.org), CC BY 4.0.
Last updated 2026-09-23.